Unique ID issued by UMIN | UMIN000016578 |
---|---|
Receipt number | R000019225 |
Scientific Title | Examination about accuracy of quantitative vessel angiography during endovascular treatment for femoropopliteal lesions: A comparative analysis of quantitative vessel angiography and intravascular ultrasound and computed tomography |
Date of disclosure of the study information | 2015/02/23 |
Last modified on | 2016/03/13 15:23:17 |
Examination about accuracy of quantitative vessel angiography during endovascular treatment for femoropopliteal lesions: A comparative analysis of quantitative vessel angiography and intravascular ultrasound and computed tomography
Examination about accuracy of quantitative vessel angiography during endovascular treatment for femoropopliteal lesions
Examination about accuracy of quantitative vessel angiography during endovascular treatment for femoropopliteal lesions: A comparative analysis of quantitative vessel angiography and intravascular ultrasound and computed tomography
Examination about accuracy of quantitative vessel angiography during endovascular treatment for femoropopliteal lesions
Japan |
Peripheral arterial disease (PAD)
Cardiology | Vascular surgery |
Others
NO
Evaluation about accuracy of quantitative vessel angiography (QVA) during endovascular treatment for femoropopliteal lesions
Others
Evaluation about accuracy of parameters measured by QVA
Others
Others
Not applicable
1. Differences of vessel diameters measured by QVA and intravascular ultrasound (IVUS).
2. Differences of stent length measured by QVA, CT and IVUS.
Relationship between distance from calibration point and each accuracy
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1.Age>=20, male or female.
2.Getting informed consent form a patient or legal guardian.
3.Rutherford classification category 2-6 (including critical limb ischemia) and significant stenotic lesion in the femoropopliteal artery.
4.Patient scheduled to receive stent implantation.
5.Patient who already received stent implantation, and scheduled to receive endovascular therapy.
1. Previous history of allergy to contrast materials and materials used in the investigational device.
2. Estimated glomerular filtrateion rate is less than 30ml/min/1.73m2. Hemodialysis patient are not excluded.
3. Patient who is determined to be unsuitable for this study by principal investigator or subinvestigators.
30
1st name | |
Middle name | |
Last name | Shinsuke Mori |
Saiseikai Yokohama City Eastern Hospital
Cardiology
3-6-1, Shimosueyoshi, Tsurumi-ku, Yokohama, Kanagawa.
045-576-3000
hello_morisun@yahoo.co.jp
1st name | |
Middle name | |
Last name | Shinsuke Mori |
Saiseikai Yokohama City Eastern Hospital
Cardiology
3-6-1, Shimosueyoshi, Tsurumi-ku, Yokohama, Kanagawa.
045-576-3000
hello_morisun@yahoo.co.jp
Department of Cardiology, Saiseikai Yokohama City Eastern Hospital
none
Other
NO
済生会横浜市東部病院
Saiseikai Yokohama City Eastern Hospital
2015 | Year | 02 | Month | 23 | Day |
Unpublished
Completed
2015 | Year | 02 | Month | 23 | Day |
2015 | Year | 02 | Month | 23 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
Evaluation about accuracy of quantitative vessel angiography (QVA) during endovascular treatment for femoropopliteal lesions
2015 | Year | 02 | Month | 18 | Day |
2016 | Year | 03 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019225